US Stock MarketDetailed Quotes

SLP Simulations Plus

Watchlist

35.570
+0.070+0.20%

Trading Apr 28 10:23 ET

715.35MMarket Cap98.81P/E (TTM)

Simulations Plus Stock Forum

Teddy123

Apr 21 20:00

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

$Simulations Plus (SLP.US)$
FDA's Push to End Animal Testing: Simulations Plus Unveils Revolutionary NAMVantage Platform for Drug Development

Moomoo AI

Jan 9, 2024 20:04

Simulations Plus' high P/E ratio is likely due to investor expectations of strong future growth, despite stagnant earnings over the past three years. Investors seem willing to pay a premium for the stock in anticipation of its superior earnings outlook.

Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price Matching Investor Opinion

Moomoo AI

Dec 15, 2023 23:10

Simulations plus demonstrates efficient use of profits alongside solid earnings growth, but lower ROE compared to industry average is worrisome. Still, analysts predict further earnings growth.

Simulations Plus, Inc.'s (NASDAQ:SLP) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Moomoo AI

Nov 15, 2023 06:15

Kenanga Research suggests SLP Resources' performance may continue to struggle due to weak export demand and rising competition. Strong financial position and high-margin products are anticipated to maintain stability, despite Hong Leong Bank's indication of weak demand in Japan, SLP's primary market.